Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 342
CACI - Migraine and Chronic Headache Worksheet
(Updated 08/26/2026)
To determine the applicant’s eligibility for certification, the AME must review a current, detailed Clinical Progress
Note generated from a clinic visit with the treating physician or specialist no more than 90 days prior to the AME exam
which explains all items below. If the applicant meets ALL the acceptable certification criteria listed below, the AME can
issue. Applicants for first- or second- class must provide this information annually; applicants for third-class must provide the
information with each required exam.
AME MUST REVIEW ACCEPTABLE CERTIFICATION CRITERIA
A current, detailed clinical [ ] The condition stable on current regimen and no management changes
progress note from the treating are recommended.
physician verifies:
Type of headache [ ] Migraine (with or without aura), tension headache,
cluster headache.
Frequency and severity [ ] No more than one episode per month
[ ] In the last 12 months, no more than 2 outpatient clinic/urgent care visits
for symptom exacerbation (even if symptoms fully resolved)
[ ] No history of in-patient hospitalizations for headaches.
Symptoms [ ] Only mild non-disabling symptoms.
[ ] No symptoms that functionally impair vision.
[ ] NONE of the following:
• Any neurological impairment or TIA-type symptoms;
• Auras WITHOUT headaches;
• Impairment of central vision or functionally significant impairment of
peripheral vision;
• Vertigo; syncope; or mental status change.
Medications - Preventive [ ] None or any of the following alone or in combination, provided no side
effects and completed ground trial.
• ACE inhibitors (ACE-I)
• Angiotensin receptor blockers (ARB)
NOT acceptable: Tricyclic
• Beta blockers
antidepressants (TCAs),
• Calcium channel blockers (CCB),
anticonvulsants
• CGRP antagonists used only for prevention (prophylaxis).
Medications or treatment - [ ] None; or Over the Counter (OTC) headache medications; or other
Relief/Rescue modalities such as heat, traction, acupressure, and massage devices, to
prevent, stop, and treat headaches. OR
NOT acceptable: Narcotics, [ ] One or more of the following:
Fiorinal, Fioricet, or Midrin. • Triptans (monotherapy or with NSAID combination) 24 hour no-fly
Except eletriptan (Relpax) and frovatriptan (Frova): 48 hours
Detailed list of migraine
• metoclopramide (Reglan): 36 hour no-fly
medications and no fly/no SRD
• ondansetron (Zofran): 24 hour no-fly
time after use can be found
• promethazine (Phenergan): 96 hour no-fly
Pharmaceuticals - Migraine
• Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist with
Medications
24 hour no fly time: ubrogepant (Ubrelvy); Rimegepant (Nurtec)
Transcutaneous electrical nerve [ ] None OR Used alone or with acceptable adjunctive medications.
stimulation (TENS) units • Prevention (prophylactic) use: 8 hour no fly
(such as Cefaly, gammaCore,
• Relief/Rescue and therapeutic use: 24 hour no-fly
Relivion MG, or Nerivio)
NOT acceptable: If device causes sedation or cognitive changes.
AME MUST NOTE in Block 60 one of the following:
[ ] CACI qualified migraine and chronic headaches. (Documents do not need to be submitted to the FAA.)
[ ] Has current OR previous SI/AASI but now CACI qualified migraine and chronic headaches.
[ ] NOT CACI qualified migraine and chronic headaches. I have deferred. (Submit supporting documents.)
FAA Guide for Aviation Medical Examiners, Version 10/28/2026, page 342. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source.